메뉴 건너뛰기
Valuation in Life Sciences (Third Edition): A Practical Guide
Volumn , Issue , 2010, Pages 1-370
Valuation in life sciences (Third Edition): A practical guide
Author keywords

[No Author keywords available]
Indexed keywords

EID: 84892307293     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-10820-4_1     Document Type: Book
Times cited : (2)
References (17)
  • 1
    • 84892332424 scopus 로고    scopus 로고
    • AUTM, Survey summary of the AUTM U. S. Licensing Survey: FY
    • AUTM (2005) AUTM U. S. Licensing Survey: FY 2004. (Survey summary of the AUTM U. S. Licensing Survey: FY 2004)
    • (2004) AUTM U. S. Licensing Survey: FY 2004
  • 2
    • 85015692260 scopus 로고
    • The pricing of options and corporate liabilities
    • Black, F. and Scholes, M. (1973) "The Pricing of Options and Corporate Liabilities" Journal of Political Economy, 81, 637-654
    • (1973) Journal of Political Economy , vol.81 , pp. 637-654
    • Black, F.1    Scholes, M.2
  • 6
    • 0000880726 scopus 로고
    • On the computation of continuous time option prices using discrete approximations
    • Kaushik, A. (1991) "On the computation of continuous time option prices using discrete approximations", Journal of financial and quantitative analysis, (26) 4
    • (1991) Journal of Financial and Quantitative Analysis , Issue.26 , pp. 4
    • Kaushik, A.1
  • 8
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rates?
    • Kola, I. and J. Landis (2004) "Can the pharmaceutical industry reduce attrition rates?" Nat Rev Drug Discov 3(8):711-715
    • (2004) Nat Rev Drug Discov , vol.3 , Issue.8 , pp. 711-715
    • Kola, I.1    Landis, J.2
  • 10
    • 0036691412 scopus 로고    scopus 로고
    • Value of novelty?
    • Ma, P. and R. Zemmel (2002) "Value of novelty?" Nat Rev Drug Discov. 1(8):571-572
    • (2002) Nat Rev Drug Discov , vol.1 , Issue.8 , pp. 571-572
    • Ma, P.1    Zemmel, R.2
  • 13
    • 0032015175 scopus 로고    scopus 로고
    • How SmithKline-Beecham makes good resource allocation decisions
    • March/April 1998
    • Sharpe, P. and Keelin, T. (1998) "How SmithKline-Beecham makes good resource allocation decisions" Harvard Business Review, March/April 1998, 45-57
    • (1998) Harvard Business Review , pp. 45-57
    • Sharpe, P.1    Keelin, T.2
  • 14
    • 23644456717 scopus 로고    scopus 로고
    • Getting real about valuations in biotech
    • April 2005
    • Villiger, R. and Bogdan, B. (2005) "Getting real about valuations in biotech" Nature Biotechnology, April 2005, 423-428
    • (2005) Nature Biotechnology , pp. 423-428
    • Villiger, R.1    Bogdan, B.2
  • 16
    • 84892224550 scopus 로고    scopus 로고
    • What's biotech really worth?
    • June 2005
    • Villiger, R. and Bogdan, B. (2005) "What's biotech really worth?" Scrip Magazine, June 2005, 27-31
    • (2005) Scrip Magazine , pp. 27-31
    • Villiger, R.1    Bogdan, B.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.